Safety Profile of Lansoprazole
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 20 (2) , 195-205
- https://doi.org/10.2165/00002018-199920020-00008
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.1996
- Effective Maintenance Treatment of Reflux Esophagitis with Low-Dose LansoprazoleAnnals of Internal Medicine, 1996
- Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.1993
- Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritisGastroenterology, 1993
- Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndromeDigestive Diseases and Sciences, 1993
- Lansoprazole versus Omeprazole in Short-Term Treatment of Reflux Oesophagitis Results of a Scandinavian Multicentre TrialScandinavian Journal of Gastroenterology, 1993
- Gastric Endocrine Cells and Gastritis in Patients Receiving Long-Term Omeprazole TreatmentDigestion, 1992
- The Clinical Safety of OmeprazoleScandinavian Journal of Gastroenterology, 1989
- Histopathological Classification of Nonantral Gastric Endocrine Growths in ManDigestion, 1988
- Pharmacology and Toxicology of Omeprazole with Special Reference to the Effects on the Gastric MucosaScandinavian Journal of Gastroenterology, 1986